Stockreport

Alto Neuroscience Reports Full Year 2023 Financial Results and Recent Business Highlights

Alto Neuroscience, Inc.  (ANRO) 
PDF – Reported positive results from ALTO-100 and ALTO-300 Phase 2a studies demonstrating prospective replication of response prediction using Alto’s Precision Psychiatry Pl [Read more]